公开(公告)号：US20080032287A1

公开(公告)日：2008-02-07

申请号：US10589709

申请日：2005-02-18

Applicant: Charles R. Cantor ,  Chunming Ding

Inventor： Charles R. Cantor ,  Chunming Ding

IPC: C12Q1/68

CPC classification number: C12Q1/6827 ,  C12Q2600/156 ,  C12Q2525/186 ,  C12Q2535/125 ,  C12Q2565/627 ,  C12Q2545/101

Abstract: The present invention is directed to a method for detecting and quantifying rare mutations in a nucleic acid sample. The nucleic acid molecules under investigation can be either DNA or RNA. The rare mutation can be any type of functional or non-functional nucleic acid change or mutation, such as deletion, insertion, translocation, inversion, one or more base substitution or polymorphism. Therefore, the methods of the present invention are useful in detection of rare mutations in, for example, diagnostic, prognostic and follow-up applications, when the targets are rare known nucleic acid variants mixed in with the wildtype or the more common nucleic acid variant(s).

Abstract translation: 本发明涉及一种用于检测和定量核酸样品中罕见突变的方法。 正在研究的核酸分子可以是DNA或RNA。 罕见突变可以是任何类型的功能或非功能性核酸变化或突变，例如缺失，插入，易位，反转，一个或多个碱基取代或多态性。 因此，当目标是罕见的已知的与野生型或更常见的核酸变体混合的核酸变体时，本发明的方法可用于检测例如诊断，预后和随访应用中的罕见突变 （s）。

公开(公告)号：US20070275402A1

公开(公告)日：2007-11-29

申请号：US11784499

申请日：2007-04-06

Applicant: Yuk Lo ,  Rossa Chiu ,  Stephen Chim ,  Chunming Ding ,  Shengnan Jin ,  Tracy Lee ,  Fiona Lun

Inventor： Yuk Lo ,  Rossa Chiu ,  Stephen Chim ,  Chunming Ding ,  Shengnan Jin ,  Tracy Lee ,  Fiona Lun

IPC: C12Q1/68

CPC classification number: C12Q1/6883 ,  C12Q1/6827 ,  C12Q2600/154 ,  C12Q2600/156 ,  C12Q2523/125

Abstract: This application provides the use of novel fetal markers for prenatal diagnosis and monitoring of certain pregnancy-related conditions. More specifically, the invention resides in the discovery that certain CpG islands located on fetal chromosome 21 demonstrate a methylation profile that is distinct from that of the corresponding CpG islands located on maternal chromosome 21. This application also provides kits for diagnosing or monitoring of the relevant conditions.

Abstract translation: 该应用提供了新颖的胎儿标记物用于产前诊断和监测某些妊娠相关病症的用途。 更具体地，本发明在于发现位于胎儿染色体21上的某些CpG岛表现出与位于母体染色体21上的相应CpG岛不同的甲基化谱。该应用还提供用于诊断或监测相关 条件。

公开(公告)号：US20050239636A1

公开(公告)日：2005-10-27

申请号：US10503515

申请日：2003-01-30

Applicant: Mingzhi Gao ,  Haitao Liu ,  Zhulan Li ,  Jun Wang ,  Juxiu Yang ,  Tianyi Li ,  Xiaodong Wang ,  Changxiu Li ,  Chunming Ding

Inventor： Mingzhi Gao ,  Haitao Liu ,  Zhulan Li ,  Jun Wang ,  Juxiu Yang ,  Tianyi Li ,  Xiaodong Wang ,  Changxiu Li ,  Chunming Ding

IPC: C08F4/649 ,  C08F4/654 ,  C08F10/00 ,  C08F110/06 ,  B01J31/00 ,  C08F4/44

CPC classification number: C08F10/00 ,  C08F110/06 ,  C08F4/651 ,  C08F4/6494 ,  C08F4/6492 ,  C08F4/6465 ,  C08F2500/18 ,  C08F2500/12 ,  C08F2500/15 ,  C08F2500/04

Abstract: The present invention provides a solid catalyst component for the polymerization of olefins, comprising magnesium, titanium, a halogen and an electron donor, wherein said electron donor comprises at least one selected from the group consisting of polyol ester compounds of the formula (I): R1CO—O—CR3R4-A-CR5R6—O—CO—R2 (I) wherein, R1 and R2 groups, which may be identical or different, can be substituted or unsubstituted hydrocarbyl having 1 to 20 carbon atoms, R3-R6 groups, which may be identical or different, can be selected from the group consisting of hydrogen, halogen or substituted or unsubstituted hydrocarbyl having 1 to 20 carbon atoms, R1-R6 groups optionally contain one or more hetero-atoms replacing carbon, hydrogen atom or the both, said hetero-atom is selected from the group consisting of nitrogen, oxygen, sulfur, silicon, phosphorus and halogen atom, two or more of R3-R6 groups can be linked to form saturated or unsaturated monocyclic or polycyclic ring; A is a single bond or bivalent linking group with chain length between two free radicals being 1-10 atoms, wherein said bivalent linking group is selected from the group consisting of aliphatic, alicyclic and aromatic bivalent radicals, and can carry C1-C20 linear or branched substituents; one or more of carbon atom and/or hydrogen atom on above-mentioned bivalent linking group and substituents can be replaced by a hetero-atom selected from the group consisting of nitrogen, oxygen, sulfur, silicon, phosphorus, and halogen atom, and two or more said substituents on the linking group as well as above-mentioned R3-R6 groups can be linked to form saturated or unsaturated monocyclic or polycyclic ring.